Building a tuberculosis-free world: The Lancet Commission on tuberculosis

MJA Reid, N Arinaminpathy, A Bloom, BR Bloom… - The Lancet, 2019 - thelancet.com
Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

Updates on the risk factors for latent tuberculosis reactivation and their managements

JW Ai, QL Ruan, QH Liu, WH Zhang - Emerging microbes & …, 2016 - Taylor & Francis
The preventive treatment of latent tuberculosis infection (LTBI) is of great importance for the
elimination and control of tuberculosis (TB) worldwide, but existing screening methods for …

Three months of rifapentine and isoniazid for latent tuberculosis infection

TR Sterling, ME Villarino, AS Borisov… - … England Journal of …, 2011 - Mass Medical Soc
Background Treatment of latent Mycobacterium tuberculosis infection is an essential
component of tuberculosis control and elimination. The current standard regimen of …

Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial

R Belknap, D Holland, PJ Feng, JP Millet… - Annals of internal …, 2017 - acpjournals.org
Background: Expanding latent tuberculosis treatment is important to decrease active
disease globally. Once-weekly isoniazid and rifapentine for 12 doses is effective but limited …

Treatment of latent tuberculosis infection: an update

P Lobue, D Menzies - Respirology, 2010 - Wiley Online Library
Isoniazid (INH) has been the mainstay of treatment of latent tuberculosis infection for almost
50 years. The currently recommended preferred regimen is 9 months daily self‐administered …

Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB

SK Sharma, A Sharma, T Kadhiravan… - Evidence‐Based Child …, 2014 - Wiley Online Library
Background Preventing active tuberculosis (TB) from developing in people with latent
tuberculosis infection (LTBI) is important for global TB control. Isoniazid (INH) for six to nine …

Priorities for screening and treatment of latent tuberculosis infection in the United States

BP Linas, AY Wong, KA Freedberg… - American journal of …, 2011 - atsjournals.org
Rationale: To improve the effectiveness of tuberculosis (TB) control programs in the United
States by identifying cost-effective priorities for screening for latent tuberculosis infection …

The societal cost of heroin use disorder in the United States

R Jiang, I Lee, TA Lee, AS Pickard - PloS one, 2017 - journals.plos.org
Objective Heroin use in the United States has reached epidemic proportions. The objective
of this paper is to estimate the annual societal cost of heroin use disorder in the United …

Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States

D Shepardson, SM Marks, H Chesson… - … of tuberculosis and …, 2013 - ingentaconnect.com
SETTING: A large randomized controlled trial recently showed that for treating latent
tuberculous infection (LTBI) in persons at high risk of progression to tuberculosis (TB) …

4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that …

PD Ziakas, E Mylonakis - Clinical Infectious Diseases, 2009 - academic.oup.com
Background. One-third of the world's population is infected with tuberculosis, and 9 months
of isoniazid monotherapy is the treatment of choice for latent tuberculosis infection …